WVWalter Videtta

Walter Videtta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Walter Videtta has a total of 96 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Brain–lung axis in neurocritically ill patients: A critical review with a proposed clinical algorithm to guide neuroprotection

    by Francisco Zarra, Marcos Rolando, Rubén Páramo, Aditi Advilkar, Dhruv Gandhi, Muhammad Alozai, Walter Videtta

    How can we avoid secondary brain injury due to failed, delayed, or physiologically unfavorable ventilator liberation in neurosurgical patients outside of the operating room ? This question has exposed us to a dilemma between prolonged mechanical ventilation (MV)/weaning and the potential development of secondary neurological insults. In turn, one of the main dilemmas in neurocritical care units (NCCUs) is whether the neurological status of this vulnerable population might worsen as a result of prolonged MV. Accordingly, failed extubation attempts constitute one of the main risk factors that can significantly increase mortality and hospital length of stay. Given this: Should We Do Individualized Management during Extubation in Neurocritically Ill Patients? To address this question, a hypothesis-generating framework that led to the development of a Clinical Algorithm to Protect neurocritically ill patients under Mechanical Ventilation through Acute Brain Injury during extubation (CAPREVI), which synthesizes conceptually key neurological, hemodynamic, and respiratory parameters to mitigate secondary neurological insults during ventilator weaning and shorten MV duration. In addition, following the Scale for the Assessment of Narrative Review Articles (SANRA) checklist, we conducted a literature review of prospective studies (2000–2026) about weaning in neurocritically ill patients.

  • Open Access

    Distinctiveness of the Neurocritical Ill Patients: Aspects and Insights

    by Francisco Zarra, Walter Videtta

    Since the inception of the Neurocritical Care Society (NCS), neurocritical care has evolved into a rapidly expanding discipline. Within the intensive care field, neurocritical ill patients represent a highly vulnerable population compared with non-neurocritical patients, with substantial ethical complexity, facing barriers to equitable care that are pronounced in low- and middle-income countries (LMICs).

  • Should We Do an Individual Management of Septic Shock in Neurocritically Ill Patients? A Proposal of a Conceptual Algorithm

    by Marcos Rolando, Francisco Zarra, Walter Videtta

    Septic shock (SS) constitutes a complex and potentially severe entity associated with a high mortality rate worldwide.The neurocritically ill patient represents a vulnerable population with a marked tendency to develop SS . In turn, invasive neuromonitoring devices-such as external ventricular drainage (EVD)-may predispose to intracranial infections, which in some cases may progress to SS . Early goal-directed therapy (EGDT) was initially proposed by Rivers et al. for the management of SS. However, lately its application has been discussed due to its higher hospitalization costs and excessive heterogeneity among patients in the baseline inflammation levels and stage of organ dysfunction . Thus, the strategy for addressing these scenarios more effectively might be an individualized approach. To solve this research question, we proposed a novel conceptual algorithm to approach neurocritically ill patients with SS to improve the DO2/VO2 ratio and neurological outcome by optimizing the mean arterial pressure (MAP) and cerebral perfusion pressure (CPP) among other hemodynamic and neurocritical parameters.

  • Current Practices for Intracranial Pressure and Cerebral Oxygenation Monitoring in Severe Traumatic Brain Injury: A Latin American Survey

    by Daniel Agustin Godoy, Jorge Carrizosa, Sergio Aguilera, Walter Videtta, Manuel Jibaja, Latin America Brain Injury Consortium (LABIC) Members


  • The Outcome of Severe Traumatic Brain Injury in Latin America

    by Robert H. Bonow, Jason Barber, Nancy R. Temkin, Walter Videtta, Carlos Rondina, Gustavo Petroni, Silvia Lujan, Victor Alanis, Gustavo La Fuente, Arturo Lavadenz, et al.


  • Open Access

    Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care

    by Peter Le Roux, David K. Menon, Giuseppe Citerio, Paul Vespa, Mary Kay Bader, Gretchen M. Brophy, Michael N. Diringer, Nino Stocchetti, Walter Videtta, Rocco Armonda, et al.

    Neurocritical care depends, in part, on careful patient monitoring but as yet there are little data on what processes are the most important to monitor, how these should be monitored, and whether monitoring these processes is cost-effective and impacts outcome. At the same time, bioinformatics is a rapidly emerging field in critical care but as yet there is little agreement or standardization on what information is important and how it should be displayed and analyzed. The Neurocritical Care Society in collaboration with the European Society of Intensive Care Medicine, the Society for Critical Care Medicine, and the Latin America Brain Injury Consortium organized an international, multidisciplinary consensus conference to begin to address these needs. International experts from neurosurgery, neurocritical care, neurology, critical care, neuroanesthesiology, nursing, pharmacy, and informatics were recruited on the basis of their research, publication record, and expertise. They undertook a systematic literature review to develop recommendations about specific topics on physiologic processes important to the care of patients with disorders that require neurocritical care. This review does not make recommendations about treatment, imaging, and intraoperative monitoring. A multidisciplinary jury, selected for their expertise in clinical investigation and development of practice guidelines, guided this process. The GRADE system was used to develop recommendations based on literature review, discussion, integrating the literature with the participants’ collective experience, and critical review by an impartial jury. Emphasis was placed on the principle that recommendations should be based on both data quality and on trade-offs and translation into clinical practice. Strong consideration was given to providing pragmatic guidance and recommendations for bedside neuromonitoring, even in the absence of high quality data.


  • SEVERE PNEUMONIA DURING 2009 INFLUENZA A (H1N1) PANDEMIC: 48 ADULT PATIENTS ADMITTED TO AN ICU OF ARGENTINA

    by Liliana Aguilar, Fernando Rios, Daniel Pezzola, Adelina Badolati, Fernando Villarejo, Noemi Cacace, Mercedes Esteban, Walter Videtta, Constanza Arias, Monserrat Lloria, et al.

  • Manejo óptimo de la glucemia en el paciente neurocrítico

    by Daniel Agustín Godoy Torres, Alejandro Rabinstein, Walter Videtta, Francisco Murillo Cabezas

    To review the most significant studies on the pathophysiology of hypoglycaemia and hyperglycaemia in neurocritical patients and the therapeutic interventions used to control them. Available evidence shows that hypoglycaemia and hyperglycaemia increase brain injury and aggravate the prognosis, but it fails to establish the most suitable levels of blood glucose. Intensive treatment with insulin, compared with more moderate regimes, has not improved the prognosis and leads to further episodes of hypoglycaemia. Hypoglycaemia must always be avoided. Intensive treatment to control hyperglycaemia does not offer any kind of advantages and increases the likelihood of hypoglycaemia; it therefore cannot be recommended in neurocritical patients. No evidence is available showing the optimal level of blood glucose or the most suitable insulin regime, although its use is generally indicated when blood glucose levels are higher than 180-200 mg/dL. The value of the pharmacological control of blood glucose levels to improve the prognosis remains uncertain.